Action Pharma Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
10
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$110M
Action Pharma General Information
Description
Developer of novel drug candidates intended to treat cardiovascular, inflammatory, and metabolic diseases. The company's drug targets melanocortin receptors and brings these to the stage of clinical proof of concept for subsequent partnering, thereby enabling healthcare providers to prevent acute kidney failures in cardiac surgeries.
Contact Information
Website
www.actionpharma.comCorporate Office
- Brendstrupgaardsvej 102
- 8200 Aarhus
- Denmark
Corporate Office
- Brendstrupgaardsvej 102
- 8200 Aarhus
- Denmark
Action Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 15-Jun-2012 | $110M | Completed | Generating Revenue | ||
| 6. Later Stage VC (Series D) | 03-Jun-2010 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 01-Jan-2010 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 17-Jan-2008 | Completed | Generating Revenue | |||
| 3. Later Stage VC | Completed | Product Development | ||||
| 2. Later Stage VC | 27-Oct-2006 | $7.57M | $7.57M | Completed | Product Development | |
| 1. Early Stage VC | 01-Jan-2002 | Completed | Startup |
Action Pharma Patents
Action Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2009074157-A1 | Fully-modified phenyl pyrrole aminoguanidines | Inactive | 13-Dec-2007 | ||
| WO-2009071101-A1 | N-modified aminoguanidine derivatives | Inactive | 07-Dec-2007 | ||
| EP-2045250-A1 | Ring-substituted phenyl pyrrole aminoguanidine derivatives | Inactive | 26-Sep-2007 | ||
| WO-2009039859-A1 | Ring-substituted phenyl pyrrole aminoguanidine derivatives | Inactive | 26-Sep-2007 | ||
| EP-2035373-A1 | Phenyl pyrrole aminoguanidine derivatives | Active | 09-Jun-2006 | C07D207/42 |
Action Pharma Signals
Action Pharma Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Capnova | Venture Capital | Minority | ||
| Global Life Science Ventures | Venture Capital | Minority | ||
| InnovationsKapital | Venture Capital | Minority | ||
| Inventure Capital (Denmark) | Venture Capital | Minority | ||
| Scandinavian Life Science Venture | Venture Capital | Minority |
Action Pharma FAQs
-
When was Action Pharma founded?
Action Pharma was founded in 2000.
-
Where is Action Pharma headquartered?
Action Pharma is headquartered in Aarhus, Denmark.
-
What is the size of Action Pharma?
Action Pharma has 10 total employees.
-
What industry is Action Pharma in?
Action Pharma’s primary industry is Drug Discovery.
-
Is Action Pharma a private or public company?
Action Pharma is a Private company.
-
What is the current valuation of Action Pharma?
The current valuation of Action Pharma is .
-
What is Action Pharma’s current revenue?
The current revenue for Action Pharma is .
-
How much funding has Action Pharma raised over time?
Action Pharma has raised $42.1M.
-
Who are Action Pharma’s investors?
Capnova, Global Life Science Ventures, InnovationsKapital, Inventure Capital (Denmark), and Scandinavian Life Science Venture are 5 of 6 investors who have invested in Action Pharma.
-
When was Action Pharma acquired?
Action Pharma was acquired on 15-Jun-2012.
-
Who acquired Action Pharma?
Action Pharma was acquired by Abbott.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process